Pneumonia News and Research

Latest Pneumonia News and Research

Big pharma went all in to kill drug pricing negotiations

For decades, the drug industry has yelled bloody murder each time Congress considered a regulatory measure that threatened its profits.

12 Aug 2022

Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

A new study reviews recent advancements made in the development of RSV immunoprophylactic measures.

11 Aug 2022

New compound proves to be potent against more than 300 drug-resistant bacteria

Urinary tract infections are common, yet are increasingly tough to treat because the bacteria that cause them are becoming resistant to many antibiotics.

10 Aug 2022

Pressure ulcers' number and severity found to be underreported by U.S. nursing homes

Researchers at the University of Chicago have found that the number and severity of pressure ulcers suffered by Medicare residents in U.S. nursing homes is substantially underreported, leading to unreliable data that many consumers use to determine where to receive long- or short-term care.

10 Aug 2022

Researchers collaborate on a 15-month case study to analyze patient’s recovery from impaired adrenocorticotropic hormone

Recently, 'Long COVID' is becoming a significant issue worldwide. It refers to a variety of symptoms that persist over an extended period after the patient has recovered from a novel coronavirus infection (COVID-19). In many cases, it is unclear what causes Long COVID symptoms, and there is insufficient information regarding recovery time.

10 Aug 2022

CDC identifies bacteria that cause rare melioidosis in domestic environmental samples

The Centers for Disease Control and Prevention (CDC) has identified for the first time in domestic environmental samples the bacteria that causes a rare and serious disease called melioidosis.

8 Aug 2022

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

A recent paper describes the use of aprotinin, a protease inhibitor that works across several pathways, to reduce the severity of COVID-19.

8 Aug 2022

The impact of cold agglutinin syndrome on clinical presentations in COVID-19

Researchers presented two cases to highlight the impact of cold agglutinin syndrome on clinical presentations in COVID-19.

8 Aug 2022

A combined influenza and COVID-19 mRNA vaccine

A combined mRNA vaccine is capable of inducing broad and durable protection against co-infection with SARS-CoV-2 and IAV,

3 Aug 2022

Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters

In a new study, researchers assessed the impact of pre-existing immunity against SARS-CoV-2 acquired by previous infections (PI) or COVID-19 vaccination on the transmission of SARS-CoV-2 variants of concern such as Delta and Omicron.

2 Aug 2022

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

In a new study, researchers found elevated plasma levels of myosin light chain 9 (Myl9) in COVID-19 patients with a fatal disease.

2 Aug 2022

Reduced severity of COVID-19 in pregnant women during the Omicron wave

A new study assesses the clinical outcomes of COVID-19 in pregnant women to determine whether Omicron and vaccination status impacted disease severity.

1 Aug 2022

Symptoms of monkeypox differ from previous outbreaks

A new study describes the clinical characteristics of monkeypox infections during the current outbreak.

1 Aug 2022

What is the immunopathogenesis of pediatric COVID-19?

Researchers assessed the immunopathogenesis of COVID-19 infection in children.

1 Aug 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

Tannins as therapeutic agents against SARS-CoV-2

Researchers reviewed tannins as therapeutic agents against SARS-CoV-2.

29 Jul 2022

Evidence that the Huanan market in Wuhan, China, was the epicenter of the COVID-19 pandemic

Researchers analyzed data from multiple sources to determine the epicenter of the COVID-19 pandemic.

28 Jul 2022

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Researchers estimated the years of life lost during the COVID-19 pandemic in the United States.

28 Jul 2022

New AI algorithm accurately and quickly diagnoses idiopathic pulmonary fibrosis

A Nagoya University research group has developed an AI algorithm that accurately and quickly diagnoses idiopathic pulmonary fibrosis, a lung disease. The algorithm makes its diagnosis based only on information from non-invasive examinations, including lung images and medical information collected during daily medical care.

28 Jul 2022

PFAS exposure harms people's health and undermines America's economy

Daily exposure to a class of chemicals used in the production of many household items may lead to cancer, thyroid disease, and childhood obesity, a new study shows.

26 Jul 2022

Pneumonia News and Research

Latest Pneumonia News and Research

Big pharma went all in to kill drug pricing negotiations

Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

New compound proves to be potent against more than 300 drug-resistant bacteria

Pressure ulcers' number and severity found to be underreported by U.S. nursing homes

Researchers collaborate on a 15-month case study to analyze patient’s recovery from impaired adrenocorticotropic hormone

CDC identifies bacteria that cause rare melioidosis in domestic environmental samples

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

The impact of cold agglutinin syndrome on clinical presentations in COVID-19

A combined influenza and COVID-19 mRNA vaccine

Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

Reduced severity of COVID-19 in pregnant women during the Omicron wave

Symptoms of monkeypox differ from previous outbreaks

What is the immunopathogenesis of pediatric COVID-19?

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Tannins as therapeutic agents against SARS-CoV-2

Evidence that the Huanan market in Wuhan, China, was the epicenter of the COVID-19 pandemic

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

New AI algorithm accurately and quickly diagnoses idiopathic pulmonary fibrosis

PFAS exposure harms people's health and undermines America's economy

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pneumonia News and Research

Latest Pneumonia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in